FDA requests additional information on a formulation component -HUNTSVILLE, AL, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc.
The global oncology market is rapidly shifting toward smarter drug-delivery systems that enhance efficacy, reduce toxicity and improve patient outcomes. Traditional oral or IV drugs often face poor ...
Nanomedicine Innovations Transforming Oncology Drug Delivery And Bioavailability - Financial News Media. NetworkNewsWire Editorial Coverage New York, NY – October 29, 2025 – The global cancer-therapy ...
Despite the approval of numerous antibody-drug conjugates (ADCs), their therapeutic index remains limited by off-target toxicity resulting from linker instability. To address this challenge, the ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
Celltrion announced on November 5 that it will present preclinical results for its multi-antibody new drug, CT-P72/ABP-102, at the SITC 2025 (Society ...
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an ...
Critical care medicine presents unique challenges for pharmacotherapy due to profound pathophysiological alterations that affect drug absorption, distribution, metabolism and excretion.
Tectonic Therapeutic, Inc., a clinical stage biotechnology company specializing in therapeutic proteins and antibodies that target G-protein coupled receptors (GPCRs), has announced its inclusion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback